Aneurysm devices with additional anchoring mechanisms and associated systems and methods

Information

  • Patent Grant
  • 11344311
  • Patent Number
    11,344,311
  • Date Filed
    Monday, March 23, 2020
    4 years ago
  • Date Issued
    Tuesday, May 31, 2022
    2 years ago
Abstract
The present technology relates to aneurysm devices with additional anchoring mechanisms, and associated systems and methods. The aneurysm device is endovascularly deliverable to a site proximate an aneurysm near a parent artery with bifurcating branches. The device can include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm. The closure structure can be formed from a generally flat pattern and is transformable between a compressed configuration and a deployed configuration. The device can also have one or more lodging elements which fold to form loop elements configured for anchoring within at least one of the bifurcating branches. The struts of the lodging elements can include hinge points which bias the folding of the lodging elements. The devices further include a supplemental stabilizer connected to the closure structure and configured to reside in the parent artery.
Description
TECHNICAL FIELD

The present technology relates to implantable therapeutic devices at a target site, such as an opening at a neck of an aneurysm. In particular, the present technology is generally directed to aneurysm devices with additional anchoring mechanisms and associated systems and methods.


BACKGROUND

Many of the currently available surgical approaches for closing openings and repairing defects in anatomical lumens and tissues (e.g., blood vessels), septal defects, and other types of anatomical irregularities and defects are highly invasive. Surgical methods for clipping brain aneurysms, for example, require opening the skull, cutting or removing overlying brain tissue, clipping and repairing the aneurysm from outside the blood vessel, and then reassembling tissue and closing the skull. The risks related to anesthesia, bleeding, and infection associated with these types of procedures are high, and tissue that is affected during the procedure may or may not survive and continue functioning.


Minimally invasive techniques for treating aneurysms are accordingly highly desirable. In general, the minimally invasive therapeutic objective is to prevent material that collects or forms in the aneurysm cavity from entering the bloodstream and to prevent blood from entering and collecting in the aneurysm. This is often accomplished by introducing various materials and devices into the aneurysm. For example, implantable vaso-occlusive metallic structures are well known and commonly used. Many conventional vaso-occlusive devices have helical coils constructed from a shape memory material or noble metal that forms a desired coil configuration upon exiting the distal end of a delivery catheter. The function of the coil is to fill the space formed by an anatomical defect and to facilitate the formation of an embolus with the associated allied tissue. Multiple coils of the same or different structures may be implanted serially in a single aneurysm or other vessel defect during a procedure. Implantable framework structures are also used in an attempt to stabilize the wall of the aneurysm or defect prior to insertion of filling material such as coils.


It is crucial to accurately implant such vaso-occlusive devices within the internal volume of a cavity and to maintain the device within the internal volume of the aneurysm. Migration or projection of a vaso-occlusive device from the cavity may interfere with blood flow or nearby physiological structures and poses a serious health risk. In addition to the difficulties of delivering implantable occlusion devices, some types of aneurysms are challenging to treat because of structural features of the aneurysm or because of particularities of the site. Wide-neck aneurysms, for example, are known to present particular difficulty in the placement and retention of vaso-occlusive coils. Aneurysms at sites of vascular bifurcation are another example where the anatomical structure poses challenges to methods and devices that are effective in treating the typical sidewall aneurysms. It is therefore challenging to position conventional implantable devices during deployment, prevent shifting or migration of such devices after deployment, and preserve blood flow in neighboring vessels following after deployment.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a top plan view of an aneurysm device configured in accordance with an embodiment of the technology.



FIG. 2 is a side view of the aneurysm device of FIG. 1 in a partially deployed configuration.



FIG. 3 is a view of the aneurysm device of FIGS. 1 and 2 deployed at the neck of an aneurysm and lodged at the bifurcated side artery branches.





DETAILED DESCRIPTION

The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology are directed to devices having additional anchoring mechanisms for lodging at bifurcated branches at the neck of the aneurysm. The following description provides many specific details for a thorough understanding of, and enabling description for, embodiments of the disclosure. Well-known structures, systems, and methods often associated with aneurysm treatment systems have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments of the disclosure. In addition, those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below.



FIGS. 1 and 2 illustrate an embodiment of an aneurysm device 150 configured in accordance with the present technology. In particular, FIG. 1 is a top plan view of the aneurysm device 150 in a substantially flat, pre-assembled configuration, and FIG. 2 is a side view of the aneurysm device 150 in a deployed configuration. Referring to FIG. 1, the aneurysm device 150 can comprise a closure structure 102 and a supplemental stabilizer or support 103 extending from the closure structure 102. The closure structure 102 can be a frame, scaffold, or other structure that at least partially occludes the neck of an aneurysm to prevent embolic coils or other coagulative material within the aneurysm from escaping into the bloodstream. The closure structure 102 includes a perimeter support 160 and an inner support 170. The perimeter support 160 and inner support 170 can be joined at junctions 162 and 164. The supplemental stabilizer 103 is shown in an unassembled stage in FIG. 1. Once assembled, the proximally extending sides of the closure structure 102 and the supplemental stabilizer 103 hold the curved portion of the closure structure 102 at the neck of the aneurysm.


The aneurysm device 150 can have struts 180a-d projecting proximally from the junctions 162 and 164. Struts 180a and 180c can be connected at junction 162 and struts 180b and 180d are connected at junction 164 to form the supplemental stabilizer 103 with proximal anchoring segments. In one embodiment, the struts 180a-d each include a hinge point or bend point 175a-d. The hinge points 175a-d define collapse points and allow the struts 180a-d to preferentially fold down in a manner that forms additional supporting elements for the aneurysm device 150 that can be lodged in side artery branches at an aneurysm neck.


In the embodiment illustrated in FIG. 1, the aneurysm device 150 is constructed from a substantially flat substrate by cutting, etching, stamping, or otherwise forming the framework of the closure structure 102, the unassembled supplemental stabilizer 103, and the hinge points 175a-d. The closure structure 102 and the supplemental stabilizer 103 can be constructed from a flat sheet of material having substantially uniform thickness, but in other embodiments different regions of the sheeted material can have different thicknesses corresponding to the desired thickness for portions of the closure structure 102 and/or the supplemental stabilizer 103. Further, in other embodiments the aneurysm device 150 may be formed using different techniques and/or materials.



FIG. 2 is a side view of the aneurysm device 150 in a partially deployed configuration. In particular, as the aneurysm device 150 is deployed from a delivery catheter 202, loop elements 185a and 185b form and begin to fully open. The loop elements 185a-b start to open as the delivery catheter 202 is being withdrawn and fully open when the delivery catheter 202 is fully withdrawn. As described in greater detail below with reference to FIG. 3, the loop elements 185a-b are configured to provide a mechanism for the aneurysm device 150 to anchor in bifurcated side branches when deployed across the neck of an aneurysm. In other embodiments, the loop elements 185a-b can have a different arrangement and/or the aneurysm device 150 may include a different number of loop elements 185.



FIG. 3 illustrates the aneurysm device 150 of FIGS. 1 and 2 deployed at the neck of an aneurysm A with anchoring legs 240. As mentioned above, when the aneurysm device 150 is deployed, the loop elements 185a-b open and can lodge in side branch vessels SB 1 and SB 2, respectively. The lodging of the loop elements 185a-b within the side branch vessels SB 1 and SB 2 is expected to provide additional anchoring mechanisms for the aneurysm device 150 at the aneurysm A, and is expected to provide more secured lodging/deployment of the aneurysm device 150.



FIG. 3 additionally illustrates the use of the aneurysm device 150 to retain debris and/or other materials, such as an embolic coil mass 250, within the aneurysm cavity. In one embodiment, for example, implantable devices of the present technology may be deployed to retain debris and/or previously placed materials within the aneurysm cavity. In another embodiment, implantable devices of the present technology may be deployed before placing materials, such as embolic materials, coils, and the like, in the aneurismal cavity, and then the materials may be placed through the openings in the closure structure. In this situation, the aneurysm device may be retracted following placement of the embolic materials, or it may be detached and left at the site.


EXAMPLES

1. An aneurysm device endovascularly deliverable to a site proximate an artery with bifurcating branches, the aneurysm device comprising:

    • a closure structure comprising a distal-facing aspect configured to at least partially block an opening to the aneurysm and a proximal-facing aspect configured to arch over lumina of the bifurcating branches; and
    • a supplemental stabilizer connected to the closure structure, the supplemental stabilizer configured to reside in the artery;
    • wherein the closure structure includes a hinge point at which the closure structure folds to form a loop element configured for anchoring within at least one of the bifurcating branches.


2. The aneurysm device of example 1 wherein the closure structure comprises struts.


3. The aneurysm device of example 2 wherein the hinge point is formed on one of the struts.


4. The aneurysm device of example 1 wherein the closure structure comprises four hinge points.


5. The aneurysm device of example 1 wherein the closure structure is transformable between a compressed configuration and a deployed configuration.


6. The aneurysm device of example 5, further comprising a catheter configured to retain the closure structure in the compressed configuration.


7. The aneurysm device of example 1 wherein the closure structure comprises two loop elements, each individual loop element configured to lodge in one of the bifurcating branches.


8. The aneurysm device of example 1 wherein the closure structure comprises a shape memory material.


9. A system for treating an aneurysm, the system comprising:

    • a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm, wherein the distal framework includes a plurality of struts, and wherein individual struts include a hinge point; and
    • a proximal support framework connected to the distal framework portion, the support framework configured to reside in the parent artery and biased to press outward against a luminal wall thereof.


10. The system of example 9, further comprising a delivery sheath configured to temporarily retain the distal framework in a compressed configuration.


11. The system of example 9 wherein the struts comprise a generally flexible material that preferentially bends at the hinge point.


12. The system of example 9 wherein the individual struts comprise a loop shape that bends at the hinge point.


13. The system of example 9 wherein the distal framework portion is formed from a generally flat, unassembled component into a three-dimensional, assembled component.


14. A method of treating an aneurysm located at a site proximate to a parent artery that bifurcates into downstream branches, the method comprising:

    • expanding an axially-compressed framework comprising a distal portion and a proximal portion at a site proximate to the aneurysm, wherein the distal portion comprises a plurality of struts having bend points; and
    • arching the distal portion of the framework unobtrusively over lumina of the downstream branches, wherein the struts comprise loops bent at the bend points, the loops configured to lodge in the downstream branches.


15. The method of example 14, further comprising forming the framework from a substantially flat material.


16. The method of example 14, further comprising delivering the framework to the site with a catheter, wherein delivering the framework comprises temporarily restraining the framework in a generally compressed configuration.


17. The method of example 14, further comprising extracting the framework from the parent artery.


18. The method of example 17 wherein extracting the framework comprises restraining the framework in a catheter in a generally compressed configuration.


19. The method of example 14, further comprising substantially enclosing the aneurysm with the distal portion of the framework.


20. The method of example 14, further comprising detaching the framework from a delivery device.


The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments. In particular, the clot removal devices described above with reference to particular embodiments can include one or more additional features or components, or one or more of the features described above can be omitted.


From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.


Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, B all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.

Claims
  • 1. An aneurysm device endovascularly deliverable to a site proximate a parent artery with bifurcating branches, the aneurysm device comprising: a closure structure comprising a central occlusion element configured to at least partially block an opening to an aneurysm at the site;a supplemental stabilizer connected to the closure structure and configured to arch over lumina of the bifurcating branches; andone or more lodging elements comprising struts, the struts including hinge points formed by apices extending outwardly from the struts and pointing generally toward an axis defined by a centerline of the closure structure;wherein the one or more lodging elements fold at the hinge points to form loop elements configured for extending into one of the bifurcating branches from the central occlusion element; andwherein the hinge points are offset from the centerline of the closure structure.
  • 2. The aneurysm device of claim 1, wherein the lodging elements comprise a pair of hinge points disposed on opposing sides of a respective loop element.
  • 3. The aneurysm device of claim 1, wherein the closure structure comprises a plurality of struts.
  • 4. The aneurysm device of claim 3, wherein the struts of the closure structure form a perimeter support and an inner support.
  • 5. An aneurysm device endovascularly deliverable to a site proximate a parent artery with bifurcating branches, the aneurysm device comprising: a closure structure comprising a central occlusion element configured to at least partially block an opening to an aneurysm at the site;a supplemental stabilizer connected to the closure structure and configured to arch over lumina of the bifurcating branches; andone or more lodging elements comprising struts, the struts including hinge points formed by apices extending outwardly from the struts and pointing generally toward an axis defined by a centerline of the closure structure;wherein the one or more lodging elements fold at the hinge points to form loop elements configured for extending into one of the bifurcating branches from the central occlusion element;wherein the closure structure comprises a plurality of struts;wherein the struts of the closure structure form a perimeter support and an inner support; andwherein the perimeter support and the inner support connect at one or more junctions offset from the centerline of the closure structure.
  • 6. The aneurysm device of claim 1, wherein the closure structure is transformable between a compressed configuration and a deployed configuration.
  • 7. The aneurysm device of claim 1, wherein the closure structure comprises a shape memory material.
  • 8. A system for treating an aneurysm at a site proximate a parent artery with bifurcating branches, the system comprising: a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm and one or more lodging elements configured to extend into the bifurcating branches in opposing directions from the distal-facing aspect, the lodging elements having a plurality of struts; anda proximal support framework connected to the distal framework portion and configured to press outward against a luminal wall of the parent artery;wherein the struts of the lodging elements include a hinge point at apices outwardly extending from the struts, the apices pointing generally toward an axis defined by a centerline of the distal framework portion;wherein the one or more lodging elements fold at the hinge point to form loop elements configured for anchoring within at least one of the bifurcating branches; andwherein the struts of the one or more lodging elements of the distal framework portion form a perimeter support and an inner support, the perimeter support and the inner support connecting at one or more junctions offset from the centerline of the distal framework portion.
  • 9. A system for treating an aneurysm at a site proximate a parent artery with bifurcating branches, the system comprising: a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm and one or more lodging elements configured to extend into the bifurcating branches in opposing directions from the distal-facing aspect, the one or more lodging elements having a plurality of struts; anda proximal support framework connected to the distal framework portion and configured to press outward against a luminal wall of the parent artery;wherein the struts of the lodging elements include a hinge point at apices outwardly extending from the struts, the apices pointing generally toward an axis defined by a centerline of the distal framework portion;wherein the one or more lodging elements fold at the hinge point to form loop elements configured for anchoring within at least one of the bifurcating branches; andwherein the hinge point of the lodging elements is offset from the centerline of the distal framework portion.
  • 10. The system of claim 8, wherein the struts of the lodging elements comprise a loop shape that bends at the hinge point.
  • 11. The system of claim 8, wherein the distal framework portion is formed from a generally flat, unassembled component into a three-dimensional, assembled component.
  • 12. A method of treating an aneurysm located at a site proximate to a parent artery that bifurcates into downstream branches, the method comprising: expanding an axially-compressed framework comprising a distal portion and a proximal portion at a site proximate to the aneurysm, wherein the distal portion comprises a plurality of struts, the struts comprising loops bent at bend points offset from a centerline of the distal portion, the loops configured to lodge in the downstream branches;wherein the bend points are formed by apices outwardly extending from a curve in the struts, the apices pointing generally toward an axis defined by the centerline of the distal portion.
  • 13. The method of claim 12, further comprising: forming the framework from a substantially flat material.
  • 14. The method of claim 12, further comprising: delivering the framework to the site with a catheter, wherein delivering the framework comprises temporarily restraining the framework in a generally compressed configuration.
  • 15. The method of claim 12, further comprising: extracting the framework from the site proximate the aneurysm.
  • 16. The method of claim 15, wherein the step of extracting the framework comprises restraining the framework in a catheter in a generally compressed configuration.
  • 17. The method of claim 12, further comprising: detaching the framework from a delivery device.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of pending U.S. patent application Ser. No. 14/130,738, filed on Oct. 2, 2014, which is a U.S. National Phase Application under 35 U.S.C. § 371 of International Patent Application No. PCT/US12/40558, filed Jun. 1, 2012 which claims the benefit of priority of U.S. Provisional Patent Application No. 61/493,356, filed on Jun. 3, 2011, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (461)
Number Name Date Kind
3868956 Alfidi et al. Mar 1975 A
4164045 Bokros et al. Aug 1979 A
4248234 Assenza et al. Feb 1981 A
4645495 Vaillancourt Feb 1987 A
4651751 Swendson et al. Mar 1987 A
4665906 Jervis May 1987 A
4706671 Weinrib Nov 1987 A
4710192 Liotta et al. Dec 1987 A
4739768 Engelson Apr 1988 A
4820298 Leveen et al. Apr 1989 A
4873978 Ginsburg Oct 1989 A
4909787 Danforth Mar 1990 A
4994069 Ritchart et al. Feb 1991 A
5011488 Ginsburg Apr 1991 A
5074869 Daicoff Dec 1991 A
5122136 Guglielmi et al. Jun 1992 A
5226911 Chee et al. Jul 1993 A
5250071 Palermo Oct 1993 A
5261916 Engelson Nov 1993 A
5263964 Purdy Nov 1993 A
5263974 Matsutani et al. Nov 1993 A
5271414 Partika et al. Dec 1993 A
5304195 Twyford, Jr. et al. Apr 1994 A
5334168 Hemmer Aug 1994 A
5342386 Trotta Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5527338 Purdy Jun 1996 A
5531685 Hemmer et al. Jul 1996 A
5554181 Das Sep 1996 A
5578074 Mirigian Nov 1996 A
5624449 Pham et al. Apr 1997 A
5643254 Scheldrup et al. Jul 1997 A
5665106 Hammerslag Sep 1997 A
5669931 Kupiecki et al. Sep 1997 A
5693067 Purdy Dec 1997 A
5733294 Forber et al. Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5749890 Shaknovich May 1998 A
5749894 Engelson May 1998 A
5759194 Hammerslag Jun 1998 A
5766192 Zacca Jun 1998 A
5769884 Solovay Jun 1998 A
5797953 Tekulve Aug 1998 A
5814062 Sepetka et al. Sep 1998 A
5843103 Wulfman Dec 1998 A
5855597 Jayaraman Jan 1999 A
D407818 Mariant et al. Apr 1999 S
5895391 Farnholtz Apr 1999 A
5895410 Forber et al. Apr 1999 A
5910145 Fischell et al. Jun 1999 A
5911737 Lee et al. Jun 1999 A
5916235 Guglielmi Jun 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925683 Park Jul 1999 A
5928260 Chin et al. Jul 1999 A
5933329 Tijanoc et al. Aug 1999 A
5935114 Jang et al. Aug 1999 A
5935148 Villar et al. Aug 1999 A
5951599 McCrory Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980554 Lenker et al. Nov 1999 A
5984944 Forber Nov 1999 A
6007544 Kim Dec 1999 A
6013055 Bampos et al. Jan 2000 A
6022341 Lentz Feb 2000 A
6036720 Abrams et al. Mar 2000 A
6063070 Eder May 2000 A
6063104 Villar et al. May 2000 A
6071263 Kirkman Jun 2000 A
6077291 Das Jun 2000 A
6081263 LeGall et al. Jun 2000 A
6090125 Horton Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096021 Helm et al. Aug 2000 A
6096034 Kupiecki et al. Aug 2000 A
6102917 Maitland et al. Aug 2000 A
6110191 Dehdashtian et al. Aug 2000 A
6117157 Tekulve Sep 2000 A
6139564 Teoh Oct 2000 A
6146339 Biagtan et al. Nov 2000 A
6152944 Holman et al. Nov 2000 A
6168615 Ken et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6183495 Lenker et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
RE37117 Palermo Mar 2001 E
6221066 Ferrera et al. Apr 2001 B1
6221086 Forber Apr 2001 B1
6224610 Ferrera May 2001 B1
6228052 Pohndorf May 2001 B1
6261305 Marotta et al. Jul 2001 B1
6293960 Ken Sep 2001 B1
6296622 Kurz et al. Oct 2001 B1
6309367 Boock Oct 2001 B1
6325807 Que Dec 2001 B1
6344041 Kupiecki et al. Feb 2002 B1
6344048 Chin et al. Feb 2002 B1
6361558 Hieshima et al. Mar 2002 B1
6375668 Gifford et al. Apr 2002 B1
6383174 Eder May 2002 B1
6391037 Greenhalgh May 2002 B1
6398791 Que et al. Jun 2002 B1
6478773 Gandhi et al. Nov 2002 B1
6491711 Durcan Dec 2002 B1
6517515 Eidenschink Feb 2003 B1
6530935 Wensel et al. Mar 2003 B2
6533905 Johnson et al. Mar 2003 B2
6554794 Mueller et al. Apr 2003 B1
6589256 Forber Jul 2003 B2
6592605 Lenker et al. Jul 2003 B2
6613074 Mitelberg et al. Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6626889 Simpson et al. Sep 2003 B1
6626928 Raymond et al. Sep 2003 B1
6638268 Niazi Oct 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663607 Slaikeu et al. Dec 2003 B2
6663648 Trotta Dec 2003 B1
6669795 Johnson et al. Dec 2003 B2
6672338 Esashi et al. Jan 2004 B1
6679836 Couvillon, Jr. Jan 2004 B2
6679903 Kurz Jan 2004 B2
6689141 Ferrera et al. Feb 2004 B2
6694979 Deem et al. Feb 2004 B2
6723112 Ho et al. Apr 2004 B2
6740073 Saville May 2004 B1
6740277 Howell et al. May 2004 B2
6746468 Sepetka et al. Jun 2004 B1
6780196 Chin et al. Aug 2004 B2
6790218 Jayaraman Sep 2004 B2
6802851 Jones et al. Oct 2004 B2
6811560 Jones et al. Nov 2004 B2
6824553 Samson et al. Nov 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6837870 Duchamp Jan 2005 B2
6843802 Villalobos et al. Jan 2005 B1
6855153 Saadat Feb 2005 B2
6863678 Lee et al. Mar 2005 B2
6890218 Patwardhan et al. May 2005 B2
6911037 Gainer et al. Jun 2005 B2
6936055 Ken et al. Aug 2005 B1
6939055 Durrant et al. Sep 2005 B2
6986774 Middleman et al. Jan 2006 B2
6994092 van der Burg et al. Feb 2006 B2
7011094 Rapacki et al. Mar 2006 B2
7033374 Schaefer et al. Apr 2006 B2
7033387 Zadno-Azizi et al. Apr 2006 B2
7122043 Greenhalgh et al. Oct 2006 B2
7147659 Jones Dec 2006 B2
7156871 Jones et al. Jan 2007 B2
7169177 Obara Jan 2007 B2
7229461 Chin et al. Jun 2007 B2
7232461 Ramer Jun 2007 B2
7267679 McGuckin, Jr. et al. Sep 2007 B2
7306622 Jones et al. Dec 2007 B2
7322960 Yamamoto et al. Jan 2008 B2
7343856 Blohdorn Mar 2008 B2
7387629 Vanney et al. Jun 2008 B2
7410482 Murphy et al. Aug 2008 B2
7503928 Case Mar 2009 B2
7569066 Gerberding et al. Aug 2009 B2
7608088 Jones et al. Oct 2009 B2
7662168 McGuckin, Jr. et al. Feb 2010 B2
7857825 Moran et al. Dec 2010 B2
7892247 Conston Feb 2011 B2
7892254 Klint et al. Feb 2011 B2
8016853 Griffen et al. Sep 2011 B2
8075585 Lee et al. Dec 2011 B2
8187315 Clauson et al. May 2012 B1
8262692 Rudakov Sep 2012 B2
8388650 Gerberding et al. Mar 2013 B2
8444667 Porter May 2013 B2
8470013 Duggal et al. Jun 2013 B2
8540763 Jones et al. Sep 2013 B2
8545530 Eskridge et al. Oct 2013 B2
8551132 Eskridge et al. Oct 2013 B2
8556953 Berez et al. Oct 2013 B2
8715312 Burke et al. May 2014 B2
8715338 Frid May 2014 B2
8728141 Riina et al. May 2014 B2
8747430 Porter Jun 2014 B2
8771341 Strauss et al. Jul 2014 B2
8915950 Cam et al. Dec 2014 B2
8926680 Ferrera et al. Jan 2015 B2
8956399 Cam et al. Feb 2015 B2
8979893 Gerberding et al. Mar 2015 B2
9060886 Molaei et al. Jun 2015 B2
9107670 Hannes et al. Aug 2015 B2
9119625 Bachman et al. Sep 2015 B2
9179918 Levy et al. Nov 2015 B2
9186267 Losordo Nov 2015 B2
9192388 Cam et al. Nov 2015 B2
9211124 Campbell et al. Dec 2015 B2
9232992 Heidner Jan 2016 B2
9259229 Abrams et al. Feb 2016 B2
9277924 Clarke Mar 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9532873 Kelley Jan 2017 B2
9533344 Monetti et al. Jan 2017 B2
9539011 Chen et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9539122 Burke et al. Jan 2017 B2
9539382 Nelson Jan 2017 B2
9549830 Bruszewski et al. Jan 2017 B2
9554805 Tompkins et al. Jan 2017 B2
9561125 Bowman et al. Feb 2017 B2
9572982 Burnes et al. Feb 2017 B2
9579484 Barnell Feb 2017 B2
9585642 Dinsmoor et al. Mar 2017 B2
9615831 Gerberding et al. Apr 2017 B2
9615832 Bose et al. Apr 2017 B2
9615951 Bennett et al. Apr 2017 B2
9622753 Cox Apr 2017 B2
9636115 Henry et al. May 2017 B2
9636117 Bachman May 2017 B2
9636439 Chu et al. May 2017 B2
9642675 Werneth et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655645 Staunton May 2017 B2
9655989 Cruise et al. May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662238 Dwork et al. May 2017 B2
9662425 Lilja et al. May 2017 B2
9668898 Wong Jun 2017 B2
9675477 Thompson Jun 2017 B2
9675782 Connolly Jun 2017 B2
9676022 Ensign et al. Jun 2017 B2
9692557 Murphy Jun 2017 B2
9693852 Lam et al. Jul 2017 B2
9700262 Janik et al. Jul 2017 B2
9700399 Acosta-Acevedo Jul 2017 B2
9717421 Griswold et al. Aug 2017 B2
9717500 Tieu et al. Aug 2017 B2
9717502 Teoh et al. Aug 2017 B2
9724103 Cruise et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9750565 Bloom et al. Sep 2017 B2
9757260 Greenan Sep 2017 B2
9764111 Gulachenski Sep 2017 B2
9770251 Bowman et al. Sep 2017 B2
9770577 Li et al. Sep 2017 B2
9775621 Tompkins et al. Oct 2017 B2
9775706 Peterson et al. Oct 2017 B2
9775732 Khenansho Oct 2017 B2
9788800 Mayoras, Jr. Oct 2017 B2
9795391 Saatchi et al. Oct 2017 B2
9801980 Karino et al. Oct 2017 B2
9808599 Bowman et al. Nov 2017 B2
9833252 Sepetka et al. Dec 2017 B2
9833604 Lam et al. Dec 2017 B2
9833625 Waldhauser et al. Dec 2017 B2
10004510 Gerberding Jun 2018 B2
20020026232 Marotta et al. Feb 2002 A1
20020107534 Schaefer et al. Aug 2002 A1
20030009177 Middleman et al. Jan 2003 A1
20030033003 Harrison et al. Feb 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030139802 Wulfman et al. Jul 2003 A1
20030144695 McGuckin, Jr. et al. Jul 2003 A1
20030158595 Randall Aug 2003 A1
20030171730 Kelly et al. Sep 2003 A1
20030171739 Murphy Sep 2003 A1
20030181922 Alferness Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030195385 DeVore Oct 2003 A1
20030195553 Wallace et al. Oct 2003 A1
20030199923 Khairkhahan Oct 2003 A1
20030212412 Dillard et al. Nov 2003 A1
20040019324 Duchamp Jan 2004 A1
20040044391 Porter Mar 2004 A1
20040068314 Jones et al. Apr 2004 A1
20040087998 Lee et al. May 2004 A1
20040111112 Hoffmann Jun 2004 A1
20040143254 Vanney et al. Jul 2004 A1
20040158185 Moran et al. Aug 2004 A1
20040158311 Berhow et al. Aug 2004 A1
20040167567 Cano et al. Aug 2004 A1
20040167597 Constantino et al. Aug 2004 A1
20040167602 Fischell et al. Aug 2004 A1
20040172056 Guterman et al. Sep 2004 A1
20040186491 Klint et al. Sep 2004 A1
20040193206 Gerberding et al. Sep 2004 A1
20040193246 Ferrera Sep 2004 A1
20040193253 Thorpe et al. Sep 2004 A1
20040210248 Gordon et al. Oct 2004 A1
20040210298 Rabkin et al. Oct 2004 A1
20040260241 Yamamoto et al. Dec 2004 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050025797 Wang et al. Feb 2005 A1
20050033349 Jones et al. Feb 2005 A1
20050033409 Burke et al. Feb 2005 A1
20050055049 McGuckin, Jr. et al. Mar 2005 A1
20050096728 Ramer May 2005 A1
20050177224 Fogarty et al. Aug 2005 A1
20060004436 Amarant et al. Jan 2006 A1
20060030929 Musbach Feb 2006 A1
20060052862 Kanamaru et al. Mar 2006 A1
20060058837 Bose et al. Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060106418 Seibold et al. May 2006 A1
20060200234 Hines Sep 2006 A1
20060206199 Churchwell et al. Sep 2006 A1
20060247680 Amplatz et al. Nov 2006 A1
20060259131 Molaei et al. Nov 2006 A1
20060264905 Eskridge et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070067015 Jones et al. Mar 2007 A1
20070088387 Eskridge et al. Apr 2007 A1
20070106311 Wallace et al. May 2007 A1
20070191884 Eskridge Aug 2007 A1
20070198075 Levy Aug 2007 A1
20070203567 Levy Aug 2007 A1
20070239251 Bose Oct 2007 A1
20070270902 Slazas et al. Nov 2007 A1
20080004653 Sherman et al. Jan 2008 A1
20080004692 Henson et al. Jan 2008 A1
20080039930 Jones et al. Feb 2008 A1
20080097586 Pavcnik et al. Apr 2008 A1
20080103582 Randall May 2008 A1
20080147100 Wallace Jun 2008 A1
20080183143 Palisis et al. Jul 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080269774 Garcia et al. Oct 2008 A1
20080281350 Sepetka Nov 2008 A1
20080319533 Lehe Dec 2008 A1
20090069880 Vonderwalde et al. Mar 2009 A1
20090125053 Ferrera et al. May 2009 A1
20090299403 Chanduszko Dec 2009 A1
20090306678 Hardert et al. Dec 2009 A1
20100023105 Levy et al. Jan 2010 A1
20100063531 Rudakov et al. Mar 2010 A1
20100094335 Gerberding Apr 2010 A1
20100324649 Mattsson Dec 2010 A1
20110022149 Cox et al. Jan 2011 A1
20110270373 Sampognaro et al. Nov 2011 A1
20120143237 Cam et al. Jun 2012 A1
20120143317 Cam et al. Jun 2012 A1
20120245674 Molaei et al. Sep 2012 A1
20120283768 Cox et al. Nov 2012 A1
20120290067 Cam et al. Nov 2012 A1
20120296361 Cam et al. Nov 2012 A1
20130090682 Bachman et al. Apr 2013 A1
20130204290 Clarke Aug 2013 A1
20130268046 Gerberding et al. Oct 2013 A1
20130268053 Molaei et al. Oct 2013 A1
20130274862 Cox et al. Oct 2013 A1
20130274863 Cox et al. Oct 2013 A1
20130274866 Cox et al. Oct 2013 A1
20130274868 Cox et al. Oct 2013 A1
20130304109 Abrams et al. Nov 2013 A1
20140052233 Cox et al. Feb 2014 A1
20140058420 Hannes et al. Feb 2014 A1
20140121752 Losordo et al. May 2014 A1
20140128901 Kang et al. May 2014 A1
20140135812 Divino et al. May 2014 A1
20140142608 Eskridge et al. May 2014 A1
20140180377 Bose et al. Jun 2014 A1
20140200607 Sepetka et al. Jul 2014 A1
20140236216 Gerberding Aug 2014 A1
20150039015 Gerberding Feb 2015 A1
20150142025 Brandeis May 2015 A1
20150142042 Cox May 2015 A1
20150142043 Furey May 2015 A1
20150157329 Rudakov et al. Jun 2015 A1
20150157331 Levy et al. Jun 2015 A1
20150164512 Chin et al. Jun 2015 A1
20150164665 Cam et al. Jun 2015 A1
20150182361 Ferrera et al. Jul 2015 A1
20150196305 Meyer et al. Jul 2015 A1
20150216534 Riina et al. Aug 2015 A1
20150216687 Gerberding et al. Aug 2015 A1
20150245932 Molaei et al. Sep 2015 A1
20150250628 Monstadt et al. Sep 2015 A1
20150282962 Strauss et al. Oct 2015 A1
20150327867 Bachman et al. Nov 2015 A1
20150342612 Wu et al. Dec 2015 A1
20160015395 Molaei et al. Jan 2016 A1
20160015396 Cox et al. Jan 2016 A1
20160030050 Franano et al. Feb 2016 A1
20160036153 Beaman et al. Feb 2016 A1
20160038153 Losordo et al. Feb 2016 A1
20160249936 Clarke et al. Sep 2016 A1
20170007264 Cruise et al. Jan 2017 A1
20170007265 Guo et al. Jan 2017 A1
20170020670 Murray et al. Jan 2017 A1
20170020700 Bienvenu et al. Jan 2017 A1
20170027640 Kunis et al. Feb 2017 A1
20170027692 Bonhoeffer et al. Feb 2017 A1
20170027725 Argentine Feb 2017 A1
20170035436 Morita Feb 2017 A1
20170035567 Duffy Feb 2017 A1
20170042548 Lam Feb 2017 A1
20170049596 Schabert Feb 2017 A1
20170071737 Kelley Mar 2017 A1
20170072452 Monetti et al. Mar 2017 A1
20170079671 Morero et al. Mar 2017 A1
20170079680 Bowman Mar 2017 A1
20170079766 Wang et al. Mar 2017 A1
20170079767 Leon-Yip Mar 2017 A1
20170079812 Lam et al. Mar 2017 A1
20170079817 Sepetka et al. Mar 2017 A1
20170079819 Pung et al. Mar 2017 A1
20170079820 Lam et al. Mar 2017 A1
20170086851 Wallace et al. Mar 2017 A1
20170086996 Peterson et al. Mar 2017 A1
20170095259 Tompkins et al. Apr 2017 A1
20170100126 Bowman et al. Apr 2017 A1
20170100141 Morero et al. Apr 2017 A1
20170100143 Granfield Apr 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170113023 Steingisser et al. Apr 2017 A1
20170147765 Mehta May 2017 A1
20170151032 Loisel Jun 2017 A1
20170165062 Rothstein Jun 2017 A1
20170165065 Rothstein et al. Jun 2017 A1
20170165454 Tuohy et al. Jun 2017 A1
20170172581 Bose et al. Jun 2017 A1
20170172766 Vong et al. Jun 2017 A1
20170172772 Khenansho Jun 2017 A1
20170189033 Sepetka et al. Jul 2017 A1
20170189035 Porter Jul 2017 A1
20170215902 Leynov et al. Aug 2017 A1
20170216484 Cruise et al. Aug 2017 A1
20170224350 Shimizu et al. Aug 2017 A1
20170224355 Bowman et al. Aug 2017 A1
20170224467 Piccagli et al. Aug 2017 A1
20170224511 Dwork et al. Aug 2017 A1
20170224953 Tran et al. Aug 2017 A1
20170231749 Perkins et al. Aug 2017 A1
20170252064 Staunton Sep 2017 A1
20170265983 Lam et al. Sep 2017 A1
20170281192 Tieu et al. Oct 2017 A1
20170281331 Perkins et al. Oct 2017 A1
20170281344 Costello Oct 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20170281912 Melder et al. Oct 2017 A1
20170290593 Cruise et al. Oct 2017 A1
20170290654 Sethna Oct 2017 A1
20170296324 Argentine Oct 2017 A1
20170296325 Marrocco et al. Oct 2017 A1
20170303939 Greenhalgh et al. Oct 2017 A1
20170303942 Greenhalgh et al. Oct 2017 A1
20170303947 Greenhalgh et al. Oct 2017 A1
20170303948 Wallace et al. Oct 2017 A1
20170304041 Argentine Oct 2017 A1
20170304097 Corwin et al. Oct 2017 A1
20170304595 Nagasrinivasa et al. Oct 2017 A1
20170312109 Le Nov 2017 A1
20170312484 Shipley et al. Nov 2017 A1
20170316561 Helm et al. Nov 2017 A1
20170319826 Bowman et al. Nov 2017 A1
20170333228 Orth et al. Nov 2017 A1
20170333236 Greenan Nov 2017 A1
20170333678 Bowman et al. Nov 2017 A1
20170340383 Bloom et al. Nov 2017 A1
20170348014 Wallace et al. Dec 2017 A1
20170348514 Guyon et al. Dec 2017 A1
Foreign Referenced Citations (65)
Number Date Country
2006304660 Apr 2007 AU
1298287 Jun 2001 CN
1384726 Dec 2002 CN
1399530 Feb 2003 CN
1399531 Feb 2003 CN
101489492 Jul 2009 CN
102202585 Sep 2011 CN
102762156 Oct 2012 CN
103230290 Aug 2013 CN
103381101 Nov 2013 CN
103582460 Feb 2014 CN
103607964 Feb 2014 CN
102008028308 Apr 2009 DE
0820726 Jan 1998 EP
00996372 May 2000 EP
1269935 Jan 2003 EP
1527753 May 2005 EP
1951129 Aug 2008 EP
2326259 Jun 2011 EP
2451363 May 2012 EP
2713905 Apr 2014 EP
1134421 Mar 2014 HK
2001286478 Oct 2001 JP
2002516705 Jun 2002 JP
2003512129 Apr 2003 JP
2005522266 Jul 2005 JP
2009512515 Mar 2009 JP
2013226419 Nov 2013 JP
20080081899 Sep 2008 KR
WO-9724978 Jul 1997 WO
WO-9726939 Jul 1997 WO
WO-9731672 Sep 1997 WO
WO-9823227 Jun 1998 WO
WO-9850102 Nov 1998 WO
1999002094 Jan 1999 WO
WO-9905977 Feb 1999 WO
WO-9907294 Feb 1999 WO
WO-9915225 Apr 1999 WO
WO-0013593 Mar 2000 WO
WO-0130266 May 2001 WO
WO-2001093782 Dec 2001 WO
0200139 Jan 2002 WO
WO-0213899 Feb 2002 WO
WO-02071977 Sep 2002 WO
WO-02078777 Oct 2002 WO
WO-02087690 Nov 2002 WO
WO-03059176 Jul 2003 WO
WO-03075793 Sep 2003 WO
WO-04019790 Mar 2004 WO
WO-04026149 Apr 2004 WO
WO-04105599 Dec 2004 WO
WO-05033409 Apr 2005 WO
WO-05082279 Sep 2005 WO
WO-2006119422 Nov 2006 WO
WO-2007047851 Apr 2007 WO
WO-2008151204 Dec 2008 WO
WO-2010028314 Mar 2010 WO
WO-2011029063 Mar 2011 WO
2012167156 Dec 2012 WO
WO-2012167137 Dec 2012 WO
WO-2012167150 Dec 2012 WO
WO-2013052920 Apr 2013 WO
WO-2013169380 Nov 2013 WO
WO-2014029835 Feb 2014 WO
WO-2015179377 Nov 2015 WO
Non-Patent Literature Citations (20)
Entry
Chinese Office Action issued in corresponding Chinese Application No. 201310106823.8.
https://www.thefreedictionary.com/hinge, definition of the term “hinge”, retrieved Aug. 18, 2019 (Year: 2019).
Cordis NeuroVascular, Inc.; “Masstransit Microcatheter,” Product Prochure; No. 153-8383-3; Miami Lakes, FL, USA (2003).
Cordis NeuroVascular, Inc.; “Prolwer Select Plus Microcatheter,” Product Brochure; No. 154-9877-1; Miami Lakes, FL, USA (2003).
Cordis NeuroVascular, Inc.; “Prowler Select LP Microcatheter,” Product Brochure; No. 155-5585; Miami Lakes, FL, USA (2004).
Cordis NeuroVascular, Inc.; “Rapid Transit Microcatheter,” Product Brochure; No. 152-7369-2; Miami Lakes, FL, USA (2003).
Extended European Search Report, European Application No. 06826291.4, dated Nov. 19, 2009, 7 pages.
Gupta et al. SMST-2003: Proc. Intl. Conf. Shape Memory Superelastic Technol.; Pacific Grove, CA; p. 639; 2003.
International Search Report and Written Opinion for Application No. PCT/US2010/047908, dated May 25, 2011, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2009/056133, dated Oct. 26, 2009, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2010/047908, dated Mar. 15, 2012, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2012/040552, dated Aug. 28, 2012, 14 pages.
International Search Report and Written Opinion for International Application PCT/US2012/040536, dated Oct. 15, 2012, 17 pages.
International Search Report and Written Opinion for International Application PCT/US2012/040558, dated Oct. 8, 2012, 17 pages.
International Search Report and Written Opinion for International Application PCT/US2012/059133, dated Mar. 11, 2013,15 pages.
International Search Report and Written Opinion for International Application PCT/US2013/031793, dated Jun. 26, 2013, 14 pages.
International Search Report for International Application No. PCT/US06/40907, dated May 1, 2008, 2 pages.
Micrus Copr.; “Concourse 14 Microcatheter” Product Brochure; Sunnyvale ,CA, USA.
Polytetraflouroethylene Implants, DermNet NZ, Nov. 11, 2005, http://dermetnz.org/polytetrafluoroethylene.html.
Singapore Examination Report for Singapore Application No. 200802811-0, dated Jul. 12, 2009, 7 pages.
Related Publications (1)
Number Date Country
20200214713 A1 Jul 2020 US
Provisional Applications (1)
Number Date Country
61493356 Jun 2011 US
Continuations (1)
Number Date Country
Parent 14130738 US
Child 16827286 US